Updates | Events | HIGHLIGHTS
Vesalius in the News
Vesalius Supporting Local Women Soccer Team
Vesalius is happy to support the Vancouver Westside FC Team, and especially one of our senior engineers (Michele Touchette) who plays on this team. We wish them a great season filled with success and lots of fun. Way to go Westside FC Team!
Vesalius selected to demonstrate its TMVr device and catheter system at PCR London Valves 2022
PCR London Valves is the cardiovascular european rendez-vous focussing on innovation in transcatheter therapies for valvular heart disease. This yearly event will take place at the ExCel London on November 27-29, 2022. Vesalius has been selected by the Innovation...
Vesalius to present its clinical strategy during the invest in BC – Lumira Ventures 2022 event.
The 7th annual Invest in BC event presented by Lumira Ventures will take place on November 2nd & 3rd, 2022. This event is an opportunity to bring together stakeholders in the healthcare innovation ecosystem and includes company pitches, presentations, and panel...
Vesalius update during TCT2022
Chordal replacement and annuloplasty in one device with a leaflet-independent procedure for DMR
Vesalius transfemoral DMR solution published in the EuroIntervention journal
EuroPCR 2022 was a very successful event for Vesalius. In parallel to presenting during the Innovators' Day, Vesalius solution was published in EuroIntervention, the Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions...
Vesalius is presenting its TMVr solution during the Innovators Day at EuroPCR in Paris
Dr Peter Skarsgard, Vesalius President and Chief Scientific Officer, will be presenting Vesalius TMVr solution during the Innovators Day at EuroPCR in Paris on May 19th, 2022. We believe mitral valve repair for simple or complex degenerative mitral regurgitation,...
Vesalius IP experience shared during the Access to Innovation 2022 event.
During the Access to Innovation 2022 event organized by Lifesciences BC on February 16 and 17, our Chief Operating Officer Vincent Ledoux will be speaking on a panel relating to using IP to scale companies. This conference brings together leaders from across academia,...
Vesalius celebrating 5 years of innovations
Vesalius team celebrated today 5 years of next generation engineering and advanced biomedical innovations. Advancing medicine and simplifying the treatment for Mitral Regurgitation is and will always be our priority.
Vesalius, a life sciences startup to watch according to local executive banker.
Vesalius is 1 of 4 life sciences startups to watch according to Sean Azarshahi, a VP with RBC who is very active in the life sciences space. You can find the Vancouver Tech Journal article here.
Calla TMVr System presented at TCT 2021
Calla TMVr System, our comprehensive transfemoral DMR solution, will be unveiled to the clinical community in a podium presentation in the Innovation Theatre on November 4, 3PM local time. Please come and check us out! The Transcatheter Cardiovascular Therapeutics...